Correlation Between Mineralys Therapeutics, and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Entero Therapeutics,, you can compare the effects of market volatilities on Mineralys Therapeutics, and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Entero Therapeutics,.
Diversification Opportunities for Mineralys Therapeutics, and Entero Therapeutics,
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Entero is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Entero Therapeutics,
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.88 times more return on investment than Entero Therapeutics,. However, Mineralys Therapeutics, Common is 1.14 times less risky than Entero Therapeutics,. It trades about -0.03 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.17 per unit of risk. If you would invest 1,396 in Mineralys Therapeutics, Common on August 30, 2024 and sell it today you would lose (85.00) from holding Mineralys Therapeutics, Common or give up 6.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Entero Therapeutics,
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Entero Therapeutics, |
Mineralys Therapeutics, and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Entero Therapeutics,
The main advantage of trading using opposite Mineralys Therapeutics, and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Mineralys Therapeutics, vs. Evolution Gaming Group | Mineralys Therapeutics, vs. Mativ Holdings | Mineralys Therapeutics, vs. CF Industries Holdings | Mineralys Therapeutics, vs. The Mosaic |
| Entero Therapeutics, vs. Unilever PLC ADR | Entero Therapeutics, vs. American Axle Manufacturing | Entero Therapeutics, vs. PACCAR Inc | Entero Therapeutics, vs. Weyco Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |